- Mountain Valley MD pivots between hype-filled sectors in quick succession. Previous iteration as a cannabis operation ended with assets incurring near complete losses totalling over C$10m.
- Less than a year later, Mountain Valley now claims to have developed technologies capable of revolutionizing medicines including vaccines and a treatment for COVID.
- MVMD's inventor and lead scientist has peddled the same technology for years in products like athletic supplements without success. We interview experts who pan MVMD's claims and purported science.
- Mountain Valley has no other employees with pharmaceutical experience, and is engaged in tiny deals with obscure, troubling counterparties.
- MVMD is up 2000% in the last three months fueled by prolific stock promotion and aggressive marketing. MVMD has cash of $0.06/share, but we believe the equity will prove worthless.
For further details see:
Mountain Valley MD: Aggressive Stock Promotion And Hollow Science, 100% Downside